 In addition to dismissing the suit, the court also ordered that the plaintiffs pay the legal fees for Novartis, APA and CHADD.In the conclusion to one of the other lawsuits, Judge Tagla stated "that the allegations were fully without merit.Plaintiffs failed to provide any concrete statements to document their claims."